Publisher: Icon Group International, Inc.
Category: Prescription Drugs

Prescription Drugs market research reports by Icon Group International, Inc.

(297 reports matching your criteria)
    • The 2025-2030 World Outlook for Osteoporosis Treatments

      The 2025-2030 World Outlook for Osteoporosis Treatments This study covers the world outlook for osteoporosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Atherosclerosis Drugs

      The 2025-2030 World Outlook for Atherosclerosis Drugs This study covers the world outlook for atherosclerosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs

      The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Endometriosis Hormone Therapies

      The 2025-2030 World Outlook for Endometriosis Hormone Therapies This study covers the world outlook for endometriosis hormone therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Artificial Saliva Oral Sprays

      The 2025-2030 World Outlook for Artificial Saliva Oral Sprays This study covers the world outlook for artificial saliva oral sprays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Hemophilia a Drugs

      The 2025-2030 World Outlook for Hemophilia a Drugs This study covers the world outlook for hemophilia a drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Cystic Fibrosis Drugs

      The 2025-2030 World Outlook for Cystic Fibrosis Drugs This study covers the world outlook for cystic fibrosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Hemorrhoidal Preparations

      The 2025-2030 World Outlook for Hemorrhoidal Preparations This study covers the world outlook for hemorrhoidal preparations across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Hepatitis C Therapies

      The 2025-2030 World Outlook for Hepatitis C Therapies This study covers the world outlook for hepatitis c therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Hepatitis Drugs

      The 2025-2030 World Outlook for Hepatitis Drugs This study covers the world outlook for hepatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Pulmonary Fibrosis Treatments

      The 2025-2030 World Outlook for Pulmonary Fibrosis Treatments This study covers the world outlook for pulmonary fibrosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Viral Infection Treatments

      The 2025-2030 World Outlook for Viral Infection Treatments This study covers the world outlook for viral infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Logistics for the Pharmaceutical Industries

      The 2025-2030 World Outlook for Logistics for the Pharmaceutical Industries This study covers the world outlook for logistics for the pharmaceutical industries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Overactive Bladder Therapeutics

      The 2025-2030 World Outlook for Overactive Bladder Therapeutics This study covers the world outlook for overactive bladder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Topical Antifungal Medications

      The 2025-2030 World Outlook for Topical Antifungal Medications This study covers the world outlook for topical antifungal medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Dyslipidemia Drugs

      The 2025-2030 World Outlook for Dyslipidemia Drugs This study covers the world outlook for dyslipidemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Sleeping Pills

      The 2025-2030 World Outlook for Sleeping Pills This study covers the world outlook for sleeping pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More

    • The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators

      The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators This study covers the world outlook for angiogenesis inhibitors and stimulators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Medication Adherence

      The 2025-2030 World Outlook for Medication Adherence This study covers the world outlook for medication adherence across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Glaucoma Pharmaceuticals for Hospitals

      The 2025-2030 World Outlook for Glaucoma Pharmaceuticals for Hospitals This study covers the world outlook for glaucoma pharmaceuticals for hospitals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Gastroparesis Drugs

      The 2025-2030 World Outlook for Gastroparesis Drugs This study covers the world outlook for gastroparesis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Antidepressant Drugs

      The 2025-2030 World Outlook for Antidepressant Drugs This study covers the world outlook for antidepressant drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Antidepressants for Anxiety Disorders

      The 2025-2030 World Outlook for Antidepressants for Anxiety Disorders This study covers the world outlook for antidepressants for anxiety disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Thyroid Gland Disorders Treatments

      The 2025-2030 World Outlook for Thyroid Gland Disorders Treatments This study covers the world outlook for thyroid gland disorders treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Dysphagia Management Drugs

      The 2025-2030 World Outlook for Dysphagia Management Drugs This study covers the world outlook for dysphagia management drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

2 3 4 5 6 7 8 9 10 11

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings